VMD (Viemed Healthcare) Moat Score: 4/10 (As of Jul. 08, 2026)


VMD Viemed Healthcare Inc VMD
93 GF Score
Price $11.99
GF Value $10.90
Valuation Modestly Overvalued
! 7 Warning Signs
View Full Analysis

What is Viemed Healthcare Moat Score?

Viemed Healthcare VMD -0.70% 93 Moat Score is 4 as of Jul. 08, 2026. GuruFocus rates VMD with a GF Score™ of 93/100 and a GF Value™ of $10.90 (Modestly Overvalued). The stock has 7 warning signs investors should review. Among 844 Medical Devices & Instruments companies, Viemed Healthcare ranks better than 83.29% on this metric.

Viemed Healthcare has the Moat Score of 4, which implies that the company might have Narrow Moat - Discernible but modest moat.

Viemed Healthcare has Narrow Moat: Viemed Healthcare has a discernible but modest moat due to its specialized healthcare services and customer loyalty. However, it lacks significant intellectual property or regulatory barriers to elevate it to a strong narrow moat.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Viemed Healthcare might have Narrow Moat - Discernible but modest moat.

Viemed Healthcare  (NAS:VMD) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Viemed Healthcare Moat Score Related Terms

VMD vs DCTH, VREX, SI: Moat Score Comparison

For the Medical Devices subindustry, Viemed Healthcare's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Viemed Healthcare Moat Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Viemed Healthcare's Moat Score distribution charts can be found below:

* The bar in red indicates where Viemed Healthcare's Moat Score falls into.


VMD
93GF Score
Viemed Healthcare Inc VMD
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 4 mean?
Viemed Healthcare (VMD) has a Moat Score of 4 as of Jul. 08, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, Viemed Healthcare ranks #141 out of 844 companies in the Medical Devices & Instruments industry, placing it in the top 16.7%.
Is Viemed Healthcare's Moat Score too high?
Viemed Healthcare's current Moat Score is 4. Based on the distribution chart, Viemed Healthcare ranks #141 out of 844 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Viemed Healthcare has a GF Score™ of 93/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Viemed Healthcare's Moat Score compare to DCTH and VREX?
According to the Medical Devices & Instruments industry distribution chart, Viemed Healthcare ranks #141 out of 844 companies for Moat Score. This places Viemed Healthcare in the top 17% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Medical Devices & Instruments company?
A good Moat Score depends on the Medical Devices & Instruments industry context. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. Viemed Healthcare's current Moat Score is 4. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Viemed Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Viemed Healthcare (VMD) is currently considered Modestly Overvalued. The stock's GF Value™ is $10.90, compared to a current price of $11.99 — trading 10% above its estimated fair value. The current Moat Score is 4. Viemed Healthcare's overall GF Score™ is 93/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For Viemed Healthcare (VMD), the current Moat Score is 4 as of Jul. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Viemed Healthcare (VMD) Overvalued in 2026?

Based on GuruFocus' analysis, Viemed Healthcare stock appears to be overvalued. The current stock price of $11.99 is trading 10% above its estimated GF Value™ of $10.90. GuruFocus considers Viemed Healthcare to be Modestly Overvalued.

Key valuation signals for VMD:

  • Moat Score: 4
  • GF Value™: $10.90 vs. price of $11.99 (10% above fair value)
  • GF Score™: 93/100 with 7 warning signs

No single metric tells the full story. See the VMD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Viemed Healthcare Business Description

Other Exchanges VIJ:Germany
Address 625 E. Kaliste Saloom Road, Lafayette, LA, USA, 70508
Viemed Healthcare Inc is a provider of home medical equipment ("HME") and post-acute healthcare services in the United States, with a focus on respiratory, chronic care, and women's health products and services. The Company's primary service offerings focus on effective in-home treatment, with clinical practitioners providing therapy and counseling to patients in their homes using cutting-edge technology. The company generates the majority of its revenue from medical equipment rental, sales, and supply.
93GF Score

Get the complete analysis for VMD

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$11.99
Price
$10.90
GF Value